The global alu alu cold blister films market is expected to register a market value of US$ 4.18 billion in 2023 and is projected to accumulate a valuation of US$ 7.8 billion by exhibiting a CAGR of 6.43% in the forecast period 2023 to 2033. The alu alu cold blister films market registered a CAGR of 5.3% in the historical period 2018 to 2022.
Alu alu cold blister films provide complete protection against gases, water vapor, and light. These films also provide outstanding thermo-formability, a high scale of thermal stability, and high malleability for deep drawing blister cavities, sealing ability with standard aluminum foil, and anti-counterfeit packaging. These are the growth-driving features expected to drive product demand during the forecast period.
Data Points | Key Statistics |
---|---|
Expected Market Value in 2023 | US$ 4.18 billion |
Projected Market Value in 2033 | US$ 7.8 billion |
Growth Rate (2023 to 2033) | 6.43% CAGR |
The increasing prevalence of chronic diseases due to lifestyle changes, busy work-life schedules, sedentary lifestyles, and unhealthy eating habits are creating a high demand for drugs to treat the ailments that occurred due to such habits. This is directly creating demand for these films. In addition, rising geriatric population is increasing reliance on various medications for dealing with the deteriorating normal functionalities of the aging body, which is further fuelling the demand for alu alu cold blister films in the healthcare sector.
According to the World Health Organization, the world's population above 60 years of age will nearly double from 12% to over 22% between 2015 and 2050. By 2030, 1 out of 6 people across the globe will be aged 60 years or more. These trends are projecting high demand for cold blister films in the forecast period.
Apart from this, active pharmaceutical ingredients (APIs) drugs are highly moisture-sensitive because of their complex structures and which might result in unwanted physical, chemical, or pharmacological alterations and which might reduce the drug’s effectiveness when exposed to moisture.
In order to keep the medicine and other contents safe, alu alu cold blister films are employed to offer complete protection and to prevent it from the humid environment. Therefore, the drugs have a higher demand for cold blister films consisting of aluminum foil which will escalate the overall product demand in the coming years.
On the other hand, the expanding pharmaceutical industry due to the initiatives taken by government agencies, particularly to bolster healthcare programs in developing regions, is anticipated to drive the growth of the global pharmaceutical packaging market, which will simultaneously boost the demand for alu alu cold blister films.
The booming growth in generic medicine market, increasing financial investment in healthcare facilities and product marketing through e-commerce, and rapid expansion of drug delivery market are further anticipated to create product demand in the coming years.
Geographically, the Asia Pacific dominated the market with a market share of over 32% in 2022. It is expected to retain its dominance by accumulating over 41.4% market share by end of the forecast period.
China held the maximum regional share of 34% in 2022 and it will continue to retain its lead in the forecast period. The easy availability of raw materials such as PVC and aluminum in the country is driving market growth in this region. Additionally, the presence of key players like Ningbo Dragon Packaging Technology Co., Ltd. and Shanghai Haishun New Pharmaceutical Packaging Ltd. in the region will help foster growth in the market.
In addition, the growing prevalence of contract manufacturing across emerging countries like India and China is augmenting the product demand. The continuously escalating demand for pharmaceutical packaging solutions worldwide is the major reason for outsourcing packaging services to third-party organizations. Drug manufacturers are on the lookout for such service providers in developing regions because of the easy availability of cheap labor. This will fuel sales of alu alu cold blister films in the forthcoming years.
The market in North America is expected to grow with a CAGR of 6.2% during the assessment period. Factors such as growing per capita expenditure on medicines and other healthcare products by people, robust pharmaceutical industry, and mounting investment in healthcare industry will drive growth in the market during the forecast period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Recent innovations, product launches, breakthroughs in technology, mergers, acquisitions, collaborations, and partnerships within the companies involved in manufacturing Alu Alu Cold Blister Films Markets are anticipated to create new opportunities for market expansion during the forecast period.
According to the latest study by FMI, the alu alu cold blister films market is set to grow a CAGR 6.7% during the forecast period of 2021-2031. Demand for these cold blister films will witness steady recovery in short-term, with positive growth outlook in the long run.
Upsurge in demand for healthcare products in recent years created opportunity for the cold blister films manufacturers. The rapid growth of the pharmaceutical industry witnessing for the growing requirement for cold blister films.
Blister films has been invented in 19th century for packaging of medicines, since then it has been evolved into new avenues and now the cold blister packaging is the most viable option for medicines along with other pharmaceutical products packaging.
The evolving demand for high quality and cost effective packaging in pharmaceutical industry continues to drive demand for these cold blister films. Packaging of capsules, tablets, drugs, Vials, liquid products, ampoules and syringes continue to be a lucrative avenue for cold blister films manufacturers.
Use of aluminium in cold blister packaging i.e. alu alu cold blister packaging helps provide an impermeable barrier to light, gas and moisture. It also maintains the integrity of the product, provides complete protection, and demonstrates a high patient compliance rate.
Owing to the flexible and protective properties, cold blister films become the most utilized film type in pharmaceutical sector. Over 55% of the cold blister films sales comes from the pharmaceutical industry every year across the globe.
The USA is considered as one of the most prominent region for cold blister films business. The USA alu alu cold blister films demand is set use stride on the historic pattern of boom and bust during the assessment period 2023 to 2033. Demand is likely to remain amplified in the next couple of years, owing the fast growing requirement in pharmaceutical industry.
Additionally, the country witnesses for the prominent sales share across the globe and also the high per capita spending on prescription drugs in the country compare to other developed nations in turn enhances the demand for the cold blister films.
COVID-19 pandemic increased the consumption of prescribed medicines across the US as the country has witnessed for most number of affected people during 2020 who were constantly looking for medicines and healthcare facilities. The country witnessed for approx. 35% increase in consumption of medicines in 2020 compare to 2019.
Canada is also one of the prominent pharmaceutical market across the globe. In terms of value, the country is witnessing for over US$ 21.35 Bn for pharmaceutical products sales. By looking into the huge demand, cold blister films manufacturers are attracted to the country for expanding their business throughout.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
European cold blister packaging sales is expected to reach a compound annual growth rate of 6.3% over the forecast period. Europe is considered as second largest pharmaceutical market after North America. The countries such as Germany, France, Italy, United Kingdom and Spain are contributing greatly on the regional sales share.
In terms of value the four countries contribute over US$ 125 Billion in the pharmaceutical sector. Among them Germany as an individual contribute over approx. US$ 46 Billion..
Owing to the huge potential of pharmaceutical sector these countries experienced a heavy traffic of manufacturers. The cold blister films manufacturers are always walk side by side with pharmaceutical industry and Europe is one of the prominent investment base for them to walk along. The huge pharmaceutical industry of Europe made the region more prominent for investment.
It has been observed that many countries across Europe severely affected by COVID-19 pandemic, Italy was the country witnessed for most number of cases followed by death across Europe. The pandemic created upsurge in demand for regular drugs and medicines.
Furthermore, COVID-19 outbreak has increased the research across the world for developing a vaccine and Europe is also one among them. Considering the fact that Europe is one of the most prominent region for cold blister packaging business.
Some of the leading manufacturers and suppliers of alu alu cold blister films include
Many Leading manufacturers and suppliers are focused towards longstanding contracts with pharmaceutical companies to supply blister films as per the requirement. Most of them are already planned to redevelop the size of blisters in order to provide packaging solution with the changing dimensions of pharmaceutical products.
In addition, less bio-reactive materials used in the production of blisters will continue to remain as notable trend in the cold blister packaging manufacturing landscape across all prominent regions globally.
assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Estimated Market Value (2024) | USD 29.3 billion |
---|---|
Projected Market Revenue (2034) | USD 37.8 billion |
Value CAGR (2024 to 2034) | 2.6% |
Market CAGR (2023 to 2033) | 6.1% |
---|---|
Market Valuation (2023) | USD 2.8 billion |
Market Valuation (2033) | USD 5.1 billion |
Expected Market Value in 2023 | USD 4.15 billion |
---|---|
Projected Market Value in 2033 | USD 7.4 billion |
Growth Rate (2023 to 2033) | 5.9% |
Explore Packaging Formats Insights
View ReportsThank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.